Dose-ranging study of the new beta-adrenergic antagonist nadolol in the treatment of essential hypertension.

Name: Dose-ranging study of the new beta-adrenergic antagonist nadolol in the treatment of essential hypertension.
Author: Frithz, G

Dose-ranging study of the new beta-adrenergic antagonist nadolol in the treatment of essential hypertension. — المؤلف: Frithz, G — Current medical research and opinion 1978

المؤلف: Frithz, G
النشر: Current medical research and opinion 1978
الوصف: 383-7 p.
الموضوعات: Adrenergic beta-Antagonists؛ Adult؛ Aged؛ Clinical Trials as Topic؛ Drug Administration Schedule؛ Female؛ Humans؛ Hypertension